Literature DB >> 3779660

Oncogenes with potential nuclear function: myc, myb and fos.

R N Eisenman, C B Thompson.   

Abstract

The protein products of the retroviral oncogenes, v-myc, v-myb and v-fos, and their normal cellular counterparts, the c-myc, c-myb and c-fos proto-oncogenes, have been found to be localized predominantly in the nucleus. In view of the oncogenicity of the retroviral forms of these genes, it is probable that they have central roles in the nuclear events involved in cellular proliferation and differentiation. To investigate these possibilities, detailed studies on the expression of these 'nuclear oncogenes' have been performed. The cellular forms of all three genes are normally expressed in a variety of cell types during proliferation and have RNA and protein products with short half-lives, which is consistent with the idea that they may have regulatory roles. Studies have shown that both c-myc and c-fos are induced during the stimulation of quiescent cells to enter the cell cycle and are continually expressed in replicating cells. In contrast, c-myb levels are greatest in cells as they prepare to enter and traverse S phase. Both c-myc and c-myb expression cease as cells terminally differentiate, whereas in some cell types c-fos is induced during differentiation. Unregulated expression of all three genes has distinct effects on cellular differentiation: myc seems to inhibit differentiation of several cell types when expressed at high levels; myb does not appear to effect differentiation in the systems in which it has been examined; and fos appears to be able to induce differentiation of some cell types. In most cell types, c-myc and c-myb expression is controlled primarily by posttranscriptional mechanisms, whereas c-fos expression is regulated primarily at the transcriptional level. The protein products of these oncogenes are all phosphorylated and probably undergo additional modifications. The nuclear association of these proteins is complex and apparently takes multiple forms. Taken together, these data suggest that all three nuclear oncogenes have distinct regulatory functions with respect to cellular proliferation and differentiation. Several models for function are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3779660

Source DB:  PubMed          Journal:  Cancer Surv        ISSN: 0261-2429


  7 in total

1.  Detection of a Myc-associated protein by chemical cross-linking.

Authors:  D A Gillespie; R N Eisenman
Journal:  Mol Cell Biol       Date:  1989-02       Impact factor: 4.272

2.  c-myc and c-myb protein degradation: effect of metabolic inhibitors and heat shock.

Authors:  B Lüscher; R N Eisenman
Journal:  Mol Cell Biol       Date:  1988-06       Impact factor: 4.272

Review 3.  Molecules, cancer, and the surgeon. A review of molecular biology and its implications for surgical oncology.

Authors:  J M Arbeit
Journal:  Ann Surg       Date:  1990-07       Impact factor: 12.969

4.  A short-lived nuclear phosphoprotein encoded by the human ets-2 proto-oncogene is stabilized by activation of protein kinase C.

Authors:  S Fujiwara; R J Fisher; N K Bhat; S M Diaz de la Espina; T S Papas
Journal:  Mol Cell Biol       Date:  1988-11       Impact factor: 4.272

Review 5.  Current status of tumor markers in large bowel cancer.

Authors:  M Moore; D J Jones; P F Schofield; D G Harnden
Journal:  World J Surg       Date:  1989 Jan-Feb       Impact factor: 3.352

6.  A critical appraisal of the immunohistochemical detection of the c-myc oncogene product in colorectal cancer.

Authors:  D J Jones; A K Ghosh; M Moore; P F Schofield
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640

7.  Myc oncoproteins are phosphorylated by casein kinase II.

Authors:  B Lüscher; E A Kuenzel; E G Krebs; R N Eisenman
Journal:  EMBO J       Date:  1989-04       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.